Phosphate binders to treat hyperphosphataemia are part of the medication regime of every dialysis patient. Phosphate binders are taken with every meal (three times a day). Generally, the medication adherence rates of phosphate binders are very low. This is due to inconveniences like their bad taste or their size which makes them hard to swallow. Also nephrologists have differing opinions on phosphate binders as they are aware of the dialysis patients' difficulties to deal with the amount of drugs they are prescribed. Still, phosphate binders are important drugs which have shown potential in reducing mortality by regulating the level of serum phosphate. In order to improve adherence rates, pharmacists have to advise the patients on these drugs' side effects versus the risks associated with omitting their intake.